Q.If the sequence of one strand of DNA is written as follows: 5'-ATGCATGCATGCATGCATGCATGCATGC-3'. Write down the sequence of complementary strand in 5' → 3' direction.

The key concept here is the structure of chromatin: DNA is wrapped around histone proteins to form nucleosomes, which are the basic units of chromatin. In euchromatin, the DNA is less tightly packed than in heterochromatin, but still organized into nucleosomes with linker DNA between them.

Let’s break it down step by step.

1. DNA per nucleosome: Each nucleosome core particle wraps about 146 bp of DNA around the histone octamer. However, the "nucleosome" in a broader sense includes the linker DNA that connects one nucleosome to the next. In euchromatin, the linker DNA is typically about 54 bp long. So, the total DNA associated with one nucleosome (core + linker) is approximately 146 + 54 = 200 bp. This is a standard approximation used in many exam problems.

2. Total base pairs for 200 nucleosomes: If each nucleosome accounts for 200 bp, then for 200 nucleosomes:

This matches the base pair count in options (C) and (D).

3. Length of the euchromatin: The length of DNA in B-form is about 0.34 nm per base pair (or $3.4 \times 10^{-10}$ m per bp). So, the total length of the DNA if it were fully extended would be:

But this is the length of the DNA molecule itself, not the length of the euchromatin fiber. In euchromatin, the DNA is packaged into nucleosomes, which further compact the fiber. The packing ratio (the ratio of DNA length to chromatin fiber length) for euchromatin is about 1.0 to 1.1 (i.e., the fiber is roughly the same length as the DNA, or slightly shorter). However, the options given seem to treat the euchromatin length as simply the DNA length, which is a common simplification in some exam contexts.

Let’s check the options:

• (A) 20000 bp and $13000 \times 10^{-9}$ m — bp count is wrong.
• (B) 10000 bp and $10000 \times 10^{-9}$ m — bp count is wrong.
• (C) 40000 bp and $13600 \times 10^{-9}$ m — close to our DNA length.
• (D) 40000 bp and $13900 \times 10^{-9}$ m — slightly different.

The difference between 13,600 and 13,900 nm might arise from using a slightly different linker length or a different bp spacing (e.g., 0.33 nm per bp). If we use 0.34 nm/bp, 40,000 bp gives 13,600 nm. Option (D) gives 13,900 nm, which would correspond to about 40,882 bp — not a round number. Option (C) is closer to the standard calculation.

4. Reconciling with the options: The problem likely expects the standard approximation of 200 bp per nucleosome (core + linker) and then the DNA length as $40,000 \times 0.34 \times 10^{-9} = 13,600 \times 10^{-9}$ m. This matches option (C) exactly. Option (D) is off by 300 nm, which is not negligible.

   However, some textbooks use a slightly different value for the bp spacing (e.g., 0.33 nm) or a different linker length. Given that 13,600 nm is a clean number from 40,000 × 0.34, option (C) is the most logical.

The core idea behind RNA interference (RNAi) is that a cell can use a short, double-stranded RNA molecule to "find" and destroy a specific messenger RNA (mRNA) that has a matching sequence. This is not about making new DNA or interfering with DNA synthesis — it is a post-transcriptional control mechanism. The cell essentially uses the sequence complementarity of RNA to silence a gene after it has been transcribed but before it can be translated into a protein.

Think of it like a targeted search-and-destroy mission. The double-stranded RNA is processed into small pieces (siRNAs or miRNAs). One strand of these small RNAs then acts as a guide, binding to a complementary sequence on a target mRNA. Once bound, a protein complex called RISC (RNA-induced silencing complex) cuts the mRNA, rendering it useless. The gene is effectively "silenced" because its message never gets read.

Now, let's examine each option against this concept.

1. Option (A): Synthesis of DNA and RNA using reverse transcriptase. This describes the action of retroviruses (like HIV) which use reverse transcriptase to make DNA from an RNA template. RNAi does not involve reverse transcriptase at all. This is a completely different process.

2. Option (B): Silencing of specific mRNA due to complementary RNA. This is exactly what RNAi does. The "complementary RNA" (the guide strand from the siRNA or miRNA) base-pairs with the target mRNA, leading to its silencing through degradation or blocked translation. The specificity comes from the complementary base pairing.

3. Option (C): Interference of RNA in synthesis of DNA. This is vague, but it sounds like it might refer to reverse transcription (RNA being used as a template for DNA). RNAi does not interfere with DNA synthesis; it interferes with the function of mRNA after it has been made.

4. Option (D): Synthesis of mRNA from DNA. This is transcription, the normal flow of genetic information. RNAi does not synthesize mRNA; it destroys it.

The key to this question is knowing the classic restriction map of pBR322 — one of the first widely used plasmid vectors. The ampR gene (also called bla, encoding β‑lactamase) has two well-known unique restriction sites inside it: PstI and PvuI. Cutting at either site disrupts the gene, making bacteria ampicillin-sensitive. In contrast, EcoRI and BamHI sites lie outside the ampR gene (in the tetracycline-resistance gene or other regions). The question lists four restriction sites (A, B, C, D) — you need to identify which two are in ampR.

Let’s work through it step by step.

1. Recall the pBR322 map

   pBR322 is 4361 bp long. Its two antibiotic-resistance genes are:

   • ampR (nucleotides ~3293–4153, on one strand)
   • tetR (nucleotides ~86–1276, on the other strand) The unique restriction sites are well documented:
   • EcoRI (site 0/4361) — in the tetR gene.
   • BamHI (site 375) — also in tetR.
   • PstI (site 3609) — inside ampR.
   • PvuI (site 3735) — inside ampR.

2. Match the sites to the options

   The question labels the four sites as A, B, C, D. From standard textbook diagrams:

   • A = PstI
   • B = PvuI
   • C = EcoRI
   • D = BamHI Only A and B (PstI and PvuI) lie within the ampR gene.

3. Eliminate the wrong choices

   • (A) A and D only → D (BamHI) is in tetR, not ampR.
   • (B) B and C only → C (EcoRI) is in tetR.
   • (D) C and D only → both are in tetR. Only (C) A and B only matches the known map.

The question asks you to identify three components (A, B, C) in a diagram of transcription termination in bacteria. The key is to recall the two main termination mechanisms in bacteria: Rho-dependent and Rho-independent. The presence of a specific factor (C) that binds to the RNA and helps pull it away from the DNA points directly to Rho-dependent termination.

Why this approach works:

In Rho-dependent termination, a protein called the Rho factor binds to a specific sequence on the newly made RNA (the rut site). Rho then moves along the RNA toward the RNA polymerase, which has paused at a terminator sequence. Rho unwinds the RNA-DNA hybrid, causing the transcript to be released. So in the diagram:

• A must be the RNA (the transcript being released).
• B must be RNA polymerase (the enzyme that made the RNA and is now stalled).
• C must be the Rho factor (the helicase-like protein that terminates transcription).

Now let’s confirm step by step:

1. Identify A – The wavy line being released from the complex. In transcription, the product is RNA. DNA is the template, but it stays double-stranded; the released molecule is the RNA transcript. So A is RNA, not DNA. This eliminates option (A).

2. Identify B – The large enzyme complex that synthesizes RNA. In bacteria, this is RNA polymerase. DNA polymerase is involved in replication, not transcription. So B cannot be DNA polymerase. This eliminates option (D).

3. Identify C – The factor that binds to the RNA and helps terminate. In bacteria, the Rho factor is a termination protein that binds to RNA and uses ATP to unwind the RNA-DNA hybrid. The sigma factor is involved in initiation, not termination. So C is the Rho factor, not sigma factor. This eliminates option (C).

4. Conclusion – The only remaining option is (B): A = RNA, B = RNA polymerase, C = Rho factor. This matches the known mechanism of Rho-dependent termination.

The question asks for the “R” group (the variable side chain) of each amino acid. In standard amino acid structure, the central carbon (α-carbon) is bonded to an amino group (–NH₂), a carboxyl group (–COOH), a hydrogen atom, and an R group. The R group is what distinguishes one amino acid from another. So we just need to recall the specific side chains for Glycine, Alanine, and Serine.

1. Glycine is the simplest amino acid: its R group is just a hydrogen atom (H). This is because the α-carbon is bonded to two hydrogens (one from the backbone, one as the R group). So Glycine’s R = H.

2. Alanine has a methyl group as its side chain: R = CH₃. This is a small, nonpolar, aliphatic group.

3. Serine contains a hydroxymethyl group: R = CH₂–OH. The –OH makes it polar and able to form hydrogen bonds.

Now match these to the options:

• Option (A): CH₂–OH; H; CH₂ → wrong order and wrong groups.
• Option (B): H; CH₂–OH; CH₂ → wrong for Alanine and Serine.
• Option (C): H; CH₃; CH₂–OH → exactly matches Glycine, Alanine, Serine in that order.
• Option (D): H; CH₂; CH₂–OH → Alanine’s R is CH₃, not CH₂.

The key concept here is insertional inactivation — a clever trick used in plasmid vectors like pBR322 to identify recombinant DNA. The plasmid has two antibiotic resistance genes: one for ampicillin (ampR) and one for tetracycline (tetR). Each gene contains unique restriction sites. If you insert foreign DNA into a restriction site inside a gene, that gene is disrupted and becomes non-functional. By checking which antibiotic the bacteria can no longer resist, you know the DNA was inserted there.

Let’s walk through the reasoning step by step.

1. Recall the structure of pBR322.

   pBR322 is a classic cloning vector. It has two selectable markers:

   • ampR (ampicillin resistance) — contains a unique site for Pst I.
   • tetR (tetracycline resistance) — contains unique sites for BamH I and Sal I (and also Hind III, but that’s in a different region; see below).

2. Identify which restriction sites lie in the tetracycline resistance gene.

   The tetracycline resistance gene (tetR) in pBR322 is known to have restriction sites for BamH I and Sal I. Inserting DNA at either of these sites will inactivate tetracycline resistance.

   • BamH I is indeed inside tetR.
   • EcoR I is not in either resistance gene; it lies in a non-coding region.
   • Pst I is inside the ampicillin resistance gene (ampR), not tetR.
   • Hind III is also inside tetR? Actually, careful: Hind III site is present in pBR322 but it is outside the tetR gene (it lies in the promoter region of tetR, not the coding sequence). So inserting at Hind III may reduce expression but does not fully disrupt the gene in the same way. The classic insertional inactivation for tetracycline uses BamH I or Sal I.

3. Confirm the standard teaching.

   In most biology textbooks and exam contexts, the tetracycline resistance gene of pBR322 is said to contain the restriction site for BamH I (and also Sal I). The question lists only one of these: BamH I. Therefore, the correct choice is BamH I.

The polymerase chain reaction (PCR) is one of the most powerful tools in molecular biology. Before PCR, working with a tiny amount of DNA — say, from a single hair follicle or a drop of blood at a crime scene — was nearly impossible. You simply couldn't do much analysis with so little genetic material. PCR changed that by giving us a way to amplify a specific target DNA sequence exponentially, turning a few molecules into billions in a couple of hours.

The core idea is beautifully simple: mimic what a cell does naturally when it divides (copying its DNA), but do it in a test tube, and do it over and over again in a cycle. Each cycle doubles the amount of the target DNA, so after 30 cycles you have roughly $2^{30}$ (over a billion) copies of the original piece.

Let's see why the other options don't fit.

1. Transduction is a process where bacterial DNA is transferred from one bacterium to another by a virus (a bacteriophage). It's a mechanism of horizontal gene transfer, not something PCR does. PCR is purely an in vitro (test-tube) reaction.

2. Translation is the process by which the genetic code in mRNA is read by a ribosome to build a protein. PCR works with DNA, not proteins, and involves no ribosomes or amino acids. It's a DNA replication process, not a protein synthesis one.

3. DNA digestion refers to cutting DNA into fragments, typically using enzymes called restriction endonucleases. While PCR products are often later digested for analysis (e.g., in RFLP), digestion is not the function of PCR itself. PCR's job is to make more DNA, not to cut it up.

4. DNA amplification is exactly what PCR does. The "polymerase" in the name refers to the DNA polymerase enzyme (usually Taq polymerase) that builds new DNA strands. The "chain reaction" describes the repeated cycling of temperatures that drives the exponential copying. The three steps — denaturation (separating the strands at ~95°C), annealing (primers binding at ~55°C), and extension (polymerase building new strands at ~72°C) — are repeated to amplify the target sequence.

The question tests two independent facts: the nature of the genetic code and the organization of eukaryotic genes. Let's examine each statement on its own merit.

Understanding the Genetic Code

The genetic code is the dictionary that translates nucleotide triplets (codons) into amino acids. A crucial property is degeneracy: because there are 64 possible codons ($4^3$) but only 20 standard amino acids (plus start and stop signals), multiple codons often specify the same amino acid. For example, leucine is coded by six different codons (UUA, UUG, CUU, CUC, CUA, CUG).

The assertion reverses this relationship. It claims each codon identifies more than one amino acid—that a single codon is ambiguous. This is false. The genetic code is unambiguous: each codon specifies exactly one amino acid (or stop signal). AUG always codes for methionine, never sometimes methionine and sometimes valine.

Eukaryotic Transcription Units

A transcription unit is the stretch of DNA transcribed into a single RNA molecule. In prokaryotes, one mRNA often encodes multiple proteins (polycistronic); the classic example is the lac operon, where one transcript yields three enzymes.

Eukaryotes work differently. Each mRNA typically carries the coding sequence for just one polypeptide chain—this is the monocistronic pattern. A eukaryotic gene is transcribed into pre-mRNA, processed (capping, polyadenylation, splicing), and the mature mRNA is translated into a single protein. The reason (R) correctly states this fact and correctly notes that transcription uses DNA as the template.

Evaluating the Relationship

1. Assertion (A) is false: Codons do not identify multiple amino acids; each codon is unambiguous.

2. Reason (R) is true: Eukaryotic transcription units are indeed monocistronic, and transcription synthesizes RNA from a DNA template.

3. Even if (A) were true, (R) would not explain it. The monocistronic nature of eukaryotic mRNA has nothing to do with codon ambiguity—these are unrelated aspects of molecular biology (gene organization vs. the genetic code).

The problem asks us to calculate the expected number of times a specific 8-base pair (bp) restriction site will appear in a given genome, assuming random nucleotide distribution. This is a classic application of probability for independent events.

Concept and Intuition

1. Random Nucleotide Occurrence: In DNA, there are four possible nucleotide bases: Adenine (A), Thymine (T), Cytosine (C), and Guanine (G). If their occurrence at any position is random and independent, then each base has an equal probability of $1/4$ of appearing at any given position.
2. Probability of a Specific Sequence: To find the probability of a specific sequence of bases, we multiply the probabilities of each individual base occurring in its respective position. This is because each position's base is an independent event. For example, the probability of 'AT' is $P(A) \times P(T) = (1/4) \times (1/4) = (1/4)^2$.
3. Expected Number of Occurrences: If we know the probability of a specific sequence occurring at any given starting point, and we have a long DNA strand, we can estimate how many times that sequence is expected to appear. We do this by multiplying the probability of the sequence by the total number of possible starting positions for that sequence within the DNA strand. For a genome of length $N$ and a restriction site of length $L$, there are approximately $N-L+1$ possible starting positions. Since $N$ is typically much larger than $L$, we can approximate this as $N$.

Step-by-Step Solution

1. Identify the restriction site and its length.

   The given restriction site is $5'$ GGGG CCCC $3'$.

   This sequence consists of 8 base pairs. Let $L = 8$.

2. Determine the probability of each individual nucleotide.

   Since the occurrence of nucleotide bases is random, each of the four bases (A, T, C, G) has an equal probability of appearing at any given position.

   $P(A) = P(T) = P(C) = P(G) = \frac{1}{4}$.

3. Calculate the probability of the entire 8-bp restriction site.

   The restriction site is GGGG CCCC. Since each base's occurrence is independent, the probability of this specific 8-base sequence is the product of the probabilities of each individual base in the sequence:

Calculating this value:

So, the probability of the restriction site is $\frac{1}{65536}$.

4. Determine the size of the genome.

The genome size is given as 650 kb (kilobases).

1 kilobase (kb) = 1000 base pairs (bp).

Genome size $N = 650 \times 1000 \text{ bp} = 650,000 \text{ bp}$.

5. Calculate the expected number of occurrences.

   The expected number of times the restriction site will occur in the genome is the product of the probability of the site and the total number of possible starting positions in the genome. For a genome of $N$ base pairs and a restriction site of $L$ base pairs, there are $N-L+1$ possible starting positions. Since $N$ is much larger than $L$, we can approximate the number of starting positions as $N$.

   Expected occurrences = $P(\text{restriction site}) \times N$

   Expected occurrences = $\frac{1}{65536} \times 650,000$

   Expected occurrences $\approx 9.918$

6. Compare with the given options.

   The calculated expected number of occurrences is approximately 9.918.

   Looking at the options:

   (A) 5

   (B) 10

   (C) 15

   (D) 20

   The value 9.918 is closest to 10.

The concept first: three different kinds of genetic disorder

Before matching, classify:

• Mendelian disorders — caused by an alteration in a single gene. Their transmission follows Mendel's rules and can be traced in a pedigree. Examples: haemophilia, sickle-cell anaemia, thalassemia, phenylketonuria, alkaptonuria, colour blindness.
• Chromosomal disorders — caused by absence, excess or abnormal arrangement of chromosomes, usually from non-disjunction during meiosis. Examples: Down's syndrome (trisomy 21), Klinefelter's ($XXY$), Turner's ($XO$).

List-2 item IV (non-disjunction) therefore belongs to the chromosomal class, and none of the four disorders listed is chromosomal. It is the built-in distractor — spot it and discard it.

Step-by-step

1. C) Sickle cell anaemia — (I) Point mutation. Start here; it is the most certain. A single nucleotide changes in the $\beta$-globin gene:

at the 6th position of the $\beta$-chain. This one substitution makes HbS polymerise under low $O_2$ and the RBC sickles. It is the textbook point mutation. It is autosomal recessive, but the reason asked for here is the mutation type. C → I.

2. B) Haemophilia — (V) Sex-linked recessive disorder. The gene for the clotting factor lies on the X chromosome. A carrier female ($X^{H}X^{h}$) is unaffected; she transmits the disease to half her sons. Affected females are extremely rare (they would need an affected father and a carrier mother). Famously traced through Queen Victoria's family. B → V.

3. D) Alkaptonuria — (II) Autosomal recessive metabolic disorder. One of Garrod's original inborn errors of metabolism: deficiency of homogentisate 1,2-dioxygenase blocks tyrosine breakdown, so homogentisic acid is excreted and the urine darkens on standing. Autosomal recessive. D → II.

4. A) Thalassemia — (III) Abnormal haemoglobin. By elimination, and correctly so: thalassemia arises from mutation/deletion affecting the synthesis of the $\alpha$- or $\beta$-globin chains, so haemoglobin is formed in reduced amount and abnormal composition, producing anaemia. It is a quantitative haemoglobin defect (contrast sickle-cell, which is qualitative). A → III.

5. Assemble: $A \to III,\; B \to V,\; C \to I,\; D \to II$.

Why option (A) fails

Option (A) agrees on A–III, C–I and D–II but matches haemophilia with non-disjunction (IV) — haemophilia is a single-gene, X-linked disorder, not a chromosomal aberration. That single error rules it out.

ANSWER: B